High Rejection Rate Research Articles

Interfacially Cross-Linked Polydopamine/Polybenzimidazole Composite Membranes for Organic Solvent Nanofiltration.

Interfacial cross-linking was used to prepare composite organic solvent nanofiltration (OSN) membranes comprising a polydopamine (PDA) active layer formed on a polybenzimidazole (PBI) substrate. Dibromo-p-xylene (DBX) was employed as a cross-linking agent to make the composite membranes chemically stable against harsh polar aprotic solvents. The interfacial cross-linking of PDA/PBI allowed for finely tuning the molecular weight cutoff (MWCO) of the membrane, resulting in a membrane with precise molecular separation capabilities for OSN. The morphology and surface properties of the membranes were characterized, and a membrane with a MWCO of 286 Da was investigated for OSN of a series of solvents. The membrane permeance was in the order of acetonitrile (MeCN) > methanol (MeOH) > acetone > toluene > dimethylformamide (DMF) > heptane > ethanol (EtOH) > isopropanol (IPA) > tetrahydrofuran (THF). The membranes displayed a sharp pore size distribution, yielding a rejection rate of over 99% for Rose Bengal (RB, MW 1020 g/mol) and Remazol brilliant blue (RBB, MW 626.5 g/mol) from DMF and EtOH solutions. When it came to methyl orange (MO, MW 327.3 g/mol) that had a molecular weight closer to the MWCO of the membrane, the membrane still displayed a high rejection rate of 95% and 99% in nanofiltrating solvents DMF and EtOH, respectively. In addition, it was demonstrated that the membrane was able to effectively fractionate mixed solutes having molecular weights appropriate for the MWCO rating of the membrane during OSN.

Microwave‐Assisted Fabrication of Highly Crystalline, Robust COF Membrane for Organic Solvent Nanofiltration

AbstractFabrication of crystalline, robust covalent organic framework (COF) membranes based on disorder‐to‐order strategy is promising yet highly challenging. Herein, a microwave‐assisted method for fabricating COF membranes is proposed. Initially, monomers polymerize rapidly on the surface of porous Al2O3 substrate at room temperature to form an amorphous pristine membrane. Subsequently, a microwave field is exerted to trigger fast crystallization, acquiring a crystalline COF membrane within 60 min. The amorphous pristine membrane exhibits a high dissipation factor, indicating excellent microwave absorption capability, which accelerates the dynamic reversible reactions during the microwave treatment and thus ensures a rapid transition from the amorphous to the crystalline state. Owing to the high‐crystallinity and robust structure, the COF membranes exhibit high rejection rates for solute molecules with molecular weights exceeding 700 Da (e.g., Evans blue: 98.7%) and high solvent permeance for organic solvents (e.g., ethanol: 87.8 Lm−2h−1 bar−1, n‐hexane: 222.3 Lm−2h−1 bar−1). Surprisingly, the COF membranes exhibit superior mechanical properties, with Young's modulus of 33.91 ± 3.94 GPa, outperforming previously reported polycrystalline COF membranes and are close to those for inorganic zeolite membranes. The microwave‐assisted COF crystallization method opens a new avenue to fabricating a variety of crystalline membranes for advanced separations.

The Surge in Human Papillomavirus Vaccine Rejection in Nigeria.

In October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 to 14 years. This milestone in the fight against HPV-related cancers, especially cervical cancer, faces significant challenges due to high vaccine rejection rates driven by misinformation and cultural barriers. Despite the vaccine's proven safety and efficacy, uptake remains low. This communication highlights the urgent need for a comprehensive public health education campaign to address these barriers. Proposed strategies include leveraging digital health technologies, integrating HPV education into school curricula, training community health workers, engaging religious and cultural leaders, and launching media campaigns featuring personal narratives. Implementing these evidence-based interventions is crucial for dispelling myths, misconceptions, and skepticism surrounding HPV vaccines. This will enhance acceptance and uptake, ultimately reducing cervical cancer mortality in Nigeria.

Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b-A Single-Center Experience.

Liver transplantation (LT) normalizes fasting tolerance in glycogen storage disease type (GSD) 1b. However, reported outcomes post-LT with respect to correction of neutropenia, infection risk and growth are varied. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been recently shown to improve neutropenia in GSD1b patients. In this single-center retrospective study, we reviewed all children who underwent LT for GSD1b. Neutropenia, dose of granulocyte colony-stimulating factor (G-CSF), unplanned hospital attendance, anthropometrics, graft rejection, survival, and the effects of dapagliflozin were analyzed. Data from protocol biopsies obtained at 1, 5, and 10 years post-LT and immunosuppression levels were collected. Eight children (6 female), all on G-CSF pre-transplant, underwent cadaveric LT for GSD1b at median age 3.6 years (IQR 3.3-5.1) with mean follow-up time of 10.3 years (95% CI 7.5-13.1). Neutrophil count and G-CSF requirement did not improve post-LT. Although a reduction in unplanned hospital attendance due to infection (0.98 [95% CI 0.76-1.26] vs. 0.49 [95% CI 0.41 to 0.57] per person-year, p < 0.01) was observed, gastrointestinal complaints and graft dysfunction accounted for a similar hospitalization burden pre- versus post-LT. Body mass index (BMI) reduced post-LT (Z-score 1.47 [95%CI 0.39-2.23] vs. 0.56 [95% CI -0.74 to 1.45], p = 0.02), with no significant change in height. Although all children and grafts have survived, 75% of recipients developed rejection, despite adequate immunosuppression levels, with two children having been found to have developed significant fibrosis on their 5-year protocol biopsy. Although dapagliflozin allowed cessation of G-CSF, no improvement in neutrophil count was observed. Despite this, a reduction in gastrointestinal and infection-related morbidity was noted following dapagliflozin. Although LT normalizes fasting tolerance in GSD1b and reduces hospital attendance due to infection, morbidity from infection and gastrointestinal manifestations persist. Children in our cohort experienced high rates of rejection necessitating titration of immunosuppression to balance risk of infection against organ rejection. Future studies should investigate whether early introduction of SGLT2 inhibitors post-LT impact morbidity in this group.

Donor-Specific Blood Transfusion in Lung Transplantation

Lung transplantation is still hindered by a high rate of chronic rejection necessitating profound immunosuppression with its associated complications. Donor-specific blood transfusion is a pre-transplant strategy aimed at improving graft acceptance. In contrast with standard stored blood or donor-specific regulatory T cells transfusions, this approach utilizes fresh whole blood from the donor prior to allograft transplantation, encompassing all cell types and plasma. The precise mechanisms underlying donor-specific blood transfusion-induced tolerance remain incompletely understood. Associations with regulatory/helper T cells, modulation of mononuclear phagocytic cells or microchimerism have been suggested. While numerous (pre-)clinical studies have explored its application in solid organ transplants like liver, kidney, and intestine, limited attention has been given to the setting of lung transplantation. This comprehensive review summarizes existing knowledge on the mechanisms and outcomes of donor-specific blood transfusion in solid organ transplants both in preclinical and clinical settings. We also address the potential benefits and risks associated with donor-specific blood transfusion in the field of lung transplantation, offering insights into future research directions.

Connecting Past to Present: Does Historical Redlining Affect Current Life Expectancy?

Previous research has documented a strong relationship between currently living in the redlined zones of the 1930s and suffering from a higher prevalence of disease. However, little is known about the relationship between historical redlining, modern-day redlining, and current resident health outcomes. This paper aimed to simultaneously model the associations between both historical redlining and modern-day redlining on current health outcomes. In this paper, we used structural equation modeling to uncover relationships between current and historical redlining practices and modern-day life expectancy, exploring two levels of potential mediating factors: (1) racial segregation and structural racism; and (2) mediating health outcomes. We analyzed data from 11,661 census tracts throughout the United States using historical redlining data from 1940, modern redlining data from 2010 to 2017, racial segregation and structural racism indices from 2010 to 2019, health outcome data from 2021 to 2022, and life expectancy data from 2010 to 2015. Historical redlining was measured using Home Owners' Loan Corporation (HOLC) ratings, which ranged from 1.0 for favorable neighborhoods ("greenlined") to 4.0 for unfavorable ("redlined") neighborhoods. Modern-day redlining was measured using Home Mortgage Disclosure Act (HMDA) data, which were transformed into four quartiles, ranging from level 1 (low mortgage rejection rates) to level 4 (high mortgage rejection rates). We found a significant relationship between historic redlining and current life expectancy, with average life expectancy decreasing steadily from 80.7 years in HOLC 1 tracts to 75.7 years in HOLC 4 tracts, a differential of 5.0 years between the greenlined and redlined tracts. We also found a significant relationship between modern-day redlining and current life expectancy, with average life expectancy decreasing steadily from 79.9 years in HMDA 1 tracts to 73.5 years in HMDA 4 tracts, a differential of 6.4 years. In the structural equation model, historical redlining had a total effect of decreasing life expectancy by 1.18 years for each increase of one in the HOLC rating. Modern-day redlining had a total effect of decreasing life expectancy by 1.89 years for each increase of one in the HMDA quartile. This paper provides new evidence that the legacy of redlining is not relegated to the history books but rather is a present and pressing public health issue today.

Intelligente Anlaufsteuerung für die Batteriezellenproduktion

Abstract The ramp-up of production lines as a result of changing product variants or production processes puts battery cell manufacturers under enormous quality and cost pressure due to high reject rates. A control system based on artificial intelligence methods can help to speed up the start-up processes. The InTeAn research project developed a procedure for developing a process control system to reduce ramp-up times and costs in battery cell production.

Rejected sickness cash benefit claims after 180 days of sick leave in the Swedish rehabilitation chain: A nationwide register-based study.

Since a lack of financial security among vulnerable groups could further hamper health and well-being, this study scrutinises factors predicting rejected prolonged sickness cash benefit claims among people on compensated sick leave of more than 180 days with a rejection between days 181 and 365. All 246,872 claims for employed people on sick leave recorded in the Swedish official statistics register between January 2018 and June 2021 were analysed. Claim outcome was evaluated using logistic regression with odds ratios recalculated to relative risks (RR) with 95% confidence intervals (CI), mutually adjusted for sociodemographic, work and health-related factors. Overall, 46,611 (19%) of the claims were rejected, with slightly lower rates among women (RR=0.97; 95% CI 0.95-0.99). Musculoskeletal diseases had the highest rejection rates (RR=1.84; 95% CI 1.75-1.94) followed by injuries (RR=1.57; 95% CI 1.50-1.64) and symptoms (RR=1.51; 95% CI 1.46-1.56). Mental disorders also had above-average rates (RR=1.14; 95% CI 1.09-1.19), whereas the lowest rates were found among pregnancy-related diagnoses (RR=0.13; 95% CI 0.12-0.14) and neoplasms (RR=0.18; 95% CI 0.18-0.18). Higher rates were found among immigrants (RR=1.37; 95% CI 1.34-1.40), those with only primary education (RR=1.09; 95% CI 1.06-1.12) and among blue-collar workers. The regional variation was substantial (RR range 0.41-1.72). High rejection rates were found for complex diagnoses and diagnoses with presupposed work ability in physically lighter occupations and among groups with assumed precarious positions at the labour market. Systematic differences in rates were identified between geographic regions. More studies are warranted to conclude if the differences found could be justified by other factors.

Tracheal transplantation: lessons learned that may apply to lung transplantation.

The purpose of this review is to explore the lessons learned from experimental and human tracheal transplantation to determine if this information may be applied to lung transplantation. Experimental work in animal models and the recent human tracheal transplantation suggests that a robust tracheal vascular supply prevents anastomotic complications. Further, this work demonstrates that tracheal allografts undergo a progressive chimerism as recipient epithelium repopulates the allograft. In contrast to most vascularized composite allografts such as hand and face transplantation that experience high rates of rejection, the tracheal allograft did not demonstrate rejection. This may suggest that tissue chimerism plays a role in evading immune-mediated allograft rejection. While anastomotic complications and chronic allograft rejection are the most common complications related to lung transplantation, the findings associated with tracheal transplantation may have implications for both reducing complications associated with lung transplantation.

Performance comparison of modified polyethersulfone membrane with graphene oxide and molybdenum disulfide for effective filtration of urban surface water

In the current water treatment scenario, membrane filtration is a crucial technology due to its ability to effectively remove pollutants, ensuring clean and safe water. However, a significant challenge to its widespread application is membrane fouling, which reduces membrane efficiency and service life. Various membrane modifications have been studied to enhance fouling resistance. In this work, the effect of adding graphene oxide (GO) and molybdenum disulfide (MoS2) nanoparticles for the fabrication of mixed polyethersulfone (PES) membranes was evaluated. The modified membranes were evaluated for pollutant removal efficiency and fouling resistance using model humic acid solutions and surface water samples. The PES-GO membranes demonstrated significantly improved hydrophilicity, up to 43% reduction in protein deposition, and an average flux recovery ratio (FRR) of 63%, superior to the control PES membrane, resulting in reduced fouling and sustained high permeability. Nevertheless, although PES-MoS2 exhibited high rejection rates of dissolved organic matter and UV254, they also showed higher foulant adsorption and lower FRR, likely due to the development of a colloidal fouling when treating more complex water matrices. Attenuated Total Reflectance Fourier-Transform Infrared (ATR-FTIR) analysis confirmed the deposition of organic foulants, with polysaccharides and proteins identified as major contributors to fouling. These findings suggest that while GO-enhanced PES membranes offer improved water treatment performance, modifications with MoS2 require careful consideration of feedwater composition. Future work should focus on optimizing nanoparticle integration and evaluating membrane effectiveness for diverse water sources.

Durable Mixed Chimerism May Permit Subsequent Immunosuppression-Free Intestinal Transplantation – a Proof-of-Principle Study

Intestinal transplantation (ITx) is the definitive treatment for intestinal failure but has the highest rejection rate among solid organ transplants, requiring high doses of immunosuppression with high rates of infection, graft-versus-host disease, and malignancy. Transplant tolerance would overcome the need for long-term immunosuppression. Using non-myeloablative conditioning, our laboratory has developed a novel swine model of hematopoietic stem cell transplantation (HSCT) that produces durable mixed chimerism (MC) and immune tolerance without toxicity. We investigated whether durable MC would promote tolerance of subsequently transplanted donor-matched intestinal allografts without immunosuppression. Using miniature swine with defined MHC, we performed HSCT across an MHC-Class-I haplotype mismatch. Immunosuppression was stopped by day 45. MC was evaluated by flow cytometry, and mixed lymphocyte reaction (MLR) assays were used to evaluate cellular responses. Subsequently, orthotopic ITx was performed without immunosuppression using a donor that was MHC-matched to the HSCT donor. Recipients were observed for four weeks and euthanized for tissue collection and mechanistic assays. After HSCT, the recipients developed durable multilineage MC and apparent deletional tolerance. After ITx, recipients showed no clinical or histological signs of rejection, and chimerism was unchanged. These results demonstrate the potential value of generating durable MC to achieve transplant tolerance.

Quality Control Circle Practices to Reduce Specimen Rejection Rates.

Quality assurance in laboratory testing significantly impacts patient care. The pre-analytical phase is particularly error-prone, contributing to around 70% of laboratory errors. High specimen rejection rates can delay diagnosis and treatment, cause patient discomfort, and increase healthcare costs. Quality Control Circles (QCC) have been introduced to medical institutions to improve process efficiency and reduce errors. This study aims to evaluate the effectiveness of QCC practices in reducing specimen rejection rates in a hospital clinical laboratory. A QCC initiative was implemented in the clinical laboratory from July 2021 to August 2022. The QCC comprised members from the clinical laboratory, nursing department, and administration. The initiative followed the PDCA (Plan-Do-Check-Act) cycle and involved multiple quality control methods, including flowchart analysis, Pareto analysis, and Fishbone diagrams. The effectiveness of the initiative was evaluated using statistical analyses of specimen rejection rates before and after implementation. The QCC initiative led to a significant reduction in specimen rejection rates. The monthly specimen rejection rate decreased from an average of 1.13% before the intervention to 0.27% after the intervention. The most significant factors contributing to specimen rejection were identified as lack of sample collection information and blood clotting. Targeted interventions, such as appointing specimen collection liaisons, establishing a quality control team, and providing training on blood collection procedures, were implemented. These measures resulted in a notable decrease in the proportion of rejected specimens due to the identified factors. The implementation of QCC practices effectively reduced specimen rejection rates in the hospital laboratory. The study highlights the importance of systematic quality control methods and targeted interventions in improving laboratory processes. The success of the QCC initiative demonstrates its potential for broader application in other healthcare settings to enhance quality and efficiency.

Mixed matrix membranes by post-modified UiO-66-NH2 for efficient treatment of dyeing wastewater

The preparation of modified membranes utilizing the UiO-66 framework for wastewater filtration is regarded as one of the most promising approaches to wastewater treatment, owing to its high efficiency and cost-effectiveness. In this study, a post-modified MOF, UiO-66-RSA, was synthesized via the condensation reaction of UiO-66-NH2 and 2,4-dihydroxybenzaldehyde. PVDF mixed matrix membranes (MMMs) were fabricated for the first time by mixing UiO-66-RSA into PVDF using the non-solvent induced phase separation (NIPS) method. Compared to pure PVDF membranes, the newly developed membrane, M4, demonstrated enhanced compatibility and superior mechanical strength. In dyeing wastewater treatment applications, M4 showed excellent separation efficiency for dye and heavy metal mixed wastewater, achieving rejection rates exceeding 90%. Additionally, it maintained a high flux recovery rate (FRR > 90%) and rejection rate (Rejection > 90%) after six filtration cycles of dye-containing wastewater, indicating strong recyclability. These findings suggest that MMMs embedded with UiO-66-RSA hold significant promise for dyeing wastewater treatment.

Research on Multi-Parameter Optimization of Conical Roller Line Processing Technology Based on Satisfaction Function

In the process of conical roller line processing, there will be problems such as low precision of processing parameters, long processing time, low utilization rate of machine tools, high rejection rate, and high processing cost, which will lead to low production efficiency. In order to solve this problem, it is necessary to iteratively optimize the size parameters, including inner diameter, ovality, and taper. By obtaining the optimal parameter combination, the size parameters in the production process are kept consistent, that is, the accuracy and performance of the workpiece during the processing are guaranteed so as to avoid the problem of quality difference, improve the production efficiency and reduce the processing cost. In view of the fact that there are often some constraints on the accuracy and efficiency in the machining process of tapered roller lines, how to optimize the parameters affecting the accuracy and the parameters affecting the efficiency to achieve balance between accuracy and efficiency in order to better meet the needs of customers for multi-objective optimization of the machining process has become the focus of research. Based on the existing research, this paper explores the multi-parameter optimization modeling and application in the machining process of tapered roller lines by constructing a satisfaction function, and then uses a genetic algorithm to iteratively search for the optimal solution by simulating natural selection and the genetic mechanism. Based on Python software v3.12, the production process of tapered roller bearings is simulated. The AHP analytic hierarchy process and CRITIC weight method are used to redistribute the parameter weights respectively. After eight iterations, it is concluded that the weight value assigned by the AHP analytic hierarchy process makes the satisfaction function value reach the best value of 0.99795 and tend to converge stably. The optimized parameter configuration significantly improves the machining accuracy and production efficiency of the tapered roller line. The optimal parameter combination is obtained: inner diameter: 9.9982 mm, ovality: 0.7 mm, taper: 0.5 degrees, production efficiency: 101.0.97 piece/h. In order to verify the optimization effect, the single value (X) and moving extreme difference (Rs) control charts in the measurement value control chart are used to analyze and verify the tolerance values of important parameters in the processing technology of the tapered roller line. The results show that the data points are all within the control limit, indicating that the processing process is in a statistical control state.

Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?

Canada is known to have a complex pathway for new drug approval and reimbursement, resulting in delayed access for patients with serious and life-threatening diseases, such as cancer. Several recent publications from key stakeholders, including patients, physicians and policymakers, highlight patient helplessness, physician frustrations and policymakers entangled in a massive network of bureaucracy unable to make headway. Several quantitative and qualitative assessments using time from regulatory approvals to successful reimbursements confirm long review times and high rejection rates for oncology drugs, especially those receiving conditional approvals. A consensus forum of 18 Canadian oncology clinicians recently voiced frustration with the process and inability to deliver guideline-supported efficacious therapies to their patients. This manuscript compares data extracted from publicly available data sources from 2019 to June 2024 to previous publications. Methods: Public databases from Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), which is in the process of changing to Canada's Drug Agency, and the pan-Canadian Pharmaceutical Alliance (pCPA) were reviewed and the data collected were analyzed with descriptive statistics. Results: From the data, three trends emerge, (i) an increasing number of oncology drugs are receiving conditional approvals from Health Canada, (ii) the percentage of conditionally approved oncology drugs receiving positive reimbursement recommendations from CADTH is still low but appears to be improving, but delays in access are now contingent upon pCPA deciding whether to negotiate price and then the duration of any negotiation, and (iii) real-world evidence is no longer part of the decision-making for conditional approvals. A slight increase in the positive endorsement of RWE used to support CADTH recommendations was observed. Conclusions: The lack of timely access to oncology drugs hurts Canadian patients. While a small trend of improvement appears to be emerging, longer-term data collection is required to ensure sustained patient benefits.

Effects of varying mixing ratios of components A and B on optical liquid silicone rubber

AbstractThe processing of optical liquid silicone rubber (LSR) formulations is associated with significant quality issues and high rejection rates. Often, the quality issues can be attributed to deviations in LSR dosing. To address these issues, specific mixing ratios of components A and B that deviate from the standard 1:1 ratio were intentionally created. These mixtures were characterized via differential scanning calorimetry, rheometer, and Fourier‐transform infrared spectroscopy. The mixtures were then processed via injection molding and mechanical properties such as shrinkage, density, hardness, and tensile properties were determined and analyzed. The results show that deviating mixing ratios for optical LSR have a significant influence on processing in terms of shifts in cross‐linking temperature and exothermic energy released, viscosity, and cavity pressure, as well as on the final component properties in terms of varying shrinkage, density, hardness, tensile strength, and elongation at break. This study shows that even small deviations have a major influence and should therefore be avoided. The requirements for the accuracy of the dosing system with regard to the mixing ratio must therefore be very high. In practice, such deviations in the mixing ratios are most likely to be detected in geometry via shrinkage, hardness, or tensile properties.Highlights More component A leads to faster but less dense cross‐linking Component B can be characterized by Fourier‐transform infrared spectroscopy via Si–H bending band at 905 cm−1. More component B leads to higher shrinkage, density, hardness, and strength. Deviations in the mixing ratio must be avoided as they lead to drastic changes. A general shift of the mixing ratio in favor of component B is less dramatic.

Perencanaan Strategi Untuk Mengurangi Produk Reject Dengan Pendekatan Lean Manufacturing

Company X, a feed manufacturer, faced a significant challenge related to a high product rejection rate of 10%. This study aimed to identify the root causes of the problem and implement lean manufacturing-based solutions to reduce waste. Through fishbone and Pareto analysis, the study revealed that human errors and non-standard measuring instruments were the primary contributors to the issue. The PDCA cycle was utilized as a framework for implementing solutions. The results demonstrated that the company reduced the product rejection rate by improving employee adherence to production procedures and conducting regular calibrations of measuring instruments. This research highlights the importance of lean manufacturing approaches in optimizing production processes and enhancing product quality in the feed industry.

A simple and efficient approach for pore structure optimization and hydrophilic modification of PTFE nanofiber membrane

Polytetrafluoroethylene (PTFE) membranes have great potential for treating wastewater in harsh environment due to their excellent stability. However, difficulties in the pore structure optimization and functional modification of biaxial stretched PTFE membrane have limited its further applications in liquid separation. Herein, we presented a simple and efficient approach for the preparation and hydrophilic modification of electrospun PTFE nanofiber membranes. This method involved optimizing the pore structure of PTFE nanofiber membranes through adjusting the mass ratio of the spinning carrier polyethylene oxide (PEO) and PTFE, followed by introducing the acetalized polyvinyl alcohol (PVA) on the membrane’s pore surface to improve the hydrophilicity. The average pore size changed from 288.5 to 161.3 nm, while the water contact angle reduced from 135.7° to 50.9°, which not only increased the water permeate flux from 68.56 to 1056.16 L·m−2·h−1, but also achieved high rejection rates of 99.3 % and 97.3 % for carbon (1 μm) and SiO2 (100 nm) particles respectively. Meanwhile, the obtained PTFE nanofiber membrane also exhibited excellent hydrophilic stability after long term exposure to harsh environments (pH=2 HCl, pH=12 NaOH, 1000 ppm NaClO) and 100 friction cycles (5 g weights on 1000 mesh sandpaper). This approach of preparing hydrophilic PTFE nanofiber membranes showed significant potential for practical applications in wastewater treatment.

Paying reviewers and regulating the number of papers may help fix the peer-review process

The exponential increase in the number of submissions, further accelerated by generative AI, and the decline in the availability of experts are burdening the peer review process. This has led to high unethical desk rejection rates, a growing appeal for the publication of unreviewed preprints, and a worrying proliferation of predatory journals. The idea of monetarily compensating peer reviewers has been around for many years; maybe, it is time to take it seriously as one way to save the peer review process. Here, I argue that paying reviewers, when done in a fair and transparent way, is a viable solution. Like the case of professional language editors, part-time or full-time professional reviewers, managed by universities or for-profit companies, can be an integral part of modern peer review. Being a professional reviewer could be financially attractive to retired senior researchers and to researchers who enjoy evaluating papers but are not motivated to do so for free. Moreover, not all produced research needs to go through peer review, and thus persuading researchers to limit submissions to their most novel and useful research could also help bring submission volumes to manageable levels. Overall, this paper reckons that the problem is not the peer review process per se but rather its function within an academic ecosystem dominated by an unhealthy culture of ‘publish or perish’. Instead of reforming the peer review process, academia has to look for better science dissemination schemes that promote collaboration over competition, engagement over judgement, and research quality and sustainability over quantity.

Platelet Membrane-Encapsulated Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Sildenafil for Targeted Therapy of Vein Graft Intimal Hyperplasia

Autologous vein grafts have attracted widespread attention for their high transplantation success rate and low risk of immune rejection. However, this technique is limited by the postoperative neointimal hyperplasia, recurrent stenosis and vein graft occlusion. Hence, we propose the platelet membrane-coated Poly(lactic-co-glycolic acid) (PLGA) containing sildenafil (PPS). Platelet membrane (PM) is characterised by actively targeting damaged blood vessels. The PPS can effectively target the vein grafts and then slowly release sildenafil to treat intimal hyperplasia in the vein grafts, thereby preventing the progression of vein graft restenosis. PPS effectively inhibits the proliferation and migration of vascular smooth muscle cell (VSMCs) and promotes the migration and vascularisation of human umbilical vein endothelial cells (HUVECs). In a New Zealand rabbit model of intimal hyperplasia in vein grafts, the PPS significantly suppressed vascular stenosis and intimal hyperplasia at 14 and 28 days after surgery. Thus, PPS represents a nanomedicine with therapeutic potential for treating intimal hyperplasia of vein grafts.